Glucotrack (GCTK) Debt to Equity (2016 - 2020)
Historic Debt to Equity for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to $0.02.
- Glucotrack's Debt to Equity rose 10885.85% to $0.02 in Q3 2020 from the same period last year, while for Sep 2020 it was $0.02, marking a year-over-year increase of 10885.85%. This contributed to the annual value of -$0.14 for FY2019, which is 13104.66% down from last year.
- Per Glucotrack's latest filing, its Debt to Equity stood at $0.02 for Q3 2020, which was up 10885.85% from $0.02 recorded in Q2 2020.
- Over the past 5 years, Glucotrack's Debt to Equity peaked at $11.77 during Q2 2019, and registered a low of -$0.22 during Q3 2019.
- For the 5-year period, Glucotrack's Debt to Equity averaged around $0.66, with its median value being -$0.01 (2017).
- Examining YoY changes over the last 5 years, Glucotrack's Debt to Equity showed a top increase of 11655260.41% in 2019 and a maximum decrease of 189758.55% in 2019.
- Over the past 5 years, Glucotrack's Debt to Equity (Quarter) stood at -$0.01 in 2016, then rose by 25.49% to -$0.01 in 2017, then tumbled by 430.95% to -$0.06 in 2018, then crashed by 131.05% to -$0.14 in 2019, then soared by 114.19% to $0.02 in 2020.
- Its Debt to Equity was $0.02 in Q3 2020, compared to $0.02 in Q2 2020 and $0.02 in Q1 2020.